Drugs / AOH1996
AOH1996
also known as
Proliferating Cell Nuclear Antigen Inhibitor AOH1996
targets PCNA via inhibition
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06763341 | Jul 2025 → Jan 2027 | acute myeloid leukemia | City of Hope Medical Center | Suspended | No outcome recorded |
| Phase 1 | NCT05227326 | Aug 2022 → Sep 2029 expected | leiomyosarcoma, malignant pancreatic neoplasm, non-small cell lung carcinoma, osteosarcoma +3 | City of Hope Medical Center | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AOH1996 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05227326 ↗ |
| Known as | Proliferating Cell Nuclear Antigen Inhibitor AOH1996 | “Proliferating Cell Nuclear Antigen Inhibitor AOH1996” NCT05227326 ↗ |
| Action | Inhibit | “PCNA inhibitor AOH1996” NCT05227326 ↗ |
| Route | Oral | “Given PO” NCT05227326 ↗ |
| Target | PCNA | “PCNA inhibitor AOH1996” NCT05227326 ↗ |